ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
TEMPORARY UNAVAILABILITY OF NATESTO® IN CANADA AND SOUTH KOREA
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 183260" data-attributes="member: 13851"><p><span style="font-size: 26px"><strong>Acerus Announces Resumption of <span style="color: rgb(184, 49, 47)">NATESTO®</span> Shipments</strong></span></p><p></p><p></p><p>[URL unfurl="true"]https://stockhouse.com/news/press-releases/2020/07/28/acerus-announces-resumption-of-natesto-xae-shipments[/URL]</p><p></p><p></p><p><em><span style="color: rgb(44, 130, 201)"><strong>Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF)</strong></span></em>, <em><strong>a specialty pharmaceutical company focused on the commercialization of novel prescription products for men’s health, today announced that </strong></em><span style="color: rgb(184, 49, 47)"><strong><em><u>production of new batches of NATESTO® (testosterone nasal gel) is underway and shipments are already in transit to several key markets in North America and Asia</u>.</em></strong></span></p><p></p><p><em><span style="color: rgb(184, 49, 47)"><strong><u>The first country being resupplied with NATESTO® is the United States</u>, ensuring that the product is available to meet anticipated demand in support of the recently launched Acerus Specialty SalesForce. <u>In addition, EU HWA PTE LTD, a subsidiary of Orient EuroPharma (OEP) – Acerus’ licensee across South Asia – will officially introduce NATESTO® to Taiwan at the Taiwanese Urology Association’s annual meeting August 22-23, representing the second commercial launch of NATESTO® outside North America. OEP is also preparing entry strategies for nearby markets including Hong Kong, the Philippines, Singapore, Malaysia & Vietnam</u>.</strong></span><span style="color: rgb(44, 130, 201)"> <strong><u>Separately, timelines are being finalized with respect to NATESTO® resupply in Canada and South Korea; it is currently anticipated that Acerus may be able to distribute products in these markets before the end of 2020</u>.</strong></span></em></p><p><em></em></p><p><em>“The resumption of NATESTO® production is an important achievement by the Acerus team and our supply chain partners. We are pleased with the progress already made to ensure the availability of NATESTO® for patients worldwide,” said Ed Gudaitis, President and Chief Executive Officer of Acerus. “Our team is committed to supporting OEP in their commercial efforts, and we look forward to the continued success of NATESTO® in 2020 and beyond.”</em></p></blockquote><p></p>
[QUOTE="madman, post: 183260, member: 13851"] [SIZE=26px][B]Acerus Announces Resumption of [COLOR=rgb(184, 49, 47)]NATESTO®[/COLOR] Shipments[/B][/SIZE] [URL unfurl="true"]https://stockhouse.com/news/press-releases/2020/07/28/acerus-announces-resumption-of-natesto-xae-shipments[/URL] [I][COLOR=rgb(44, 130, 201)][B]Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF)[/B][/COLOR][/I],[B] [/B][I][B]a specialty pharmaceutical company focused on the commercialization of novel prescription products for men’s health, today announced that [/B][/I][COLOR=rgb(184, 49, 47)][B][I][U]production of new batches of NATESTO® (testosterone nasal gel) is underway and shipments are already in transit to several key markets in North America and Asia[/U].[/I][/B][/COLOR] [I][COLOR=rgb(184, 49, 47)][B][U]The first country being resupplied with NATESTO® is the United States[/U], ensuring that the product is available to meet anticipated demand in support of the recently launched Acerus Specialty SalesForce. [U]In addition, EU HWA PTE LTD, a subsidiary of Orient EuroPharma (OEP) – Acerus’ licensee across South Asia – will officially introduce NATESTO® to Taiwan at the Taiwanese Urology Association’s annual meeting August 22-23, representing the second commercial launch of NATESTO® outside North America. OEP is also preparing entry strategies for nearby markets including Hong Kong, the Philippines, Singapore, Malaysia & Vietnam[/U].[/B][/COLOR][COLOR=rgb(44, 130, 201)] [B][U]Separately, timelines are being finalized with respect to NATESTO® resupply in Canada and South Korea; it is currently anticipated that Acerus may be able to distribute products in these markets before the end of 2020[/U].[/B][/COLOR] “The resumption of NATESTO® production is an important achievement by the Acerus team and our supply chain partners. We are pleased with the progress already made to ensure the availability of NATESTO® for patients worldwide,” said Ed Gudaitis, President and Chief Executive Officer of Acerus. “Our team is committed to supporting OEP in their commercial efforts, and we look forward to the continued success of NATESTO® in 2020 and beyond.”[/I] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
TEMPORARY UNAVAILABILITY OF NATESTO® IN CANADA AND SOUTH KOREA
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top